Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
Explore the potential of lorlatinib as first-line therapy for ALK+ NSCLC with Dr. Vamshi Krishna M. Learn about efficacy, safety, guideline recommendations, and its role in improving patient outcomes.
Speakers : Dr. Vamshi Krishna M
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
In this webinar, a detailed discussion is done on Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
Speakers : Dr. Sushant Mittal - Moderator ,Dr. Randeep Singh - Panelist ,Dr. Tarachand Gupta - Panelist ,Dr. Davinder Paul - Panelist
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
Early management of CNS metastases in ALK-positive NSCLC using next-gen ALK inhibitors improves intracranial control and patient outcomes.
Speakers : Dr. Davinder Paul - Panelist ,Dr. Tarachand Gupta - Panelist ,Dr. Randeep Singh - Panelist ,Dr. Sushant Mittal - Moderator
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
Explore unmet needs in ALK-positive NSCLC, including resistance, CNS metastases, biomarker-driven therapies, and advances in precision oncology.
Speakers : Dr. Davinder Paul - Panelist ,Dr. Tarachand Gupta - Panelist ,Dr. Randeep Singh - Panelist ,Dr. Sushant Mittal - Moderator
CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC
Explore innovative strategies for early CNS disease detection, integrating neuroimaging, biomarkers, and clinical assessment to enhance diagnostic precision and outcomes.
Speakers : Dr. Davinder Paul - Panelist ,Dr. Tarachand Gupta - Panelist ,Dr. Randeep Singh - Panelist ,Dr. Sushant Mittal - Moderator
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
Explore treatment sequencing strategies for ALK+ NSCLC patients with CNS diseases, focusing on targeted therapies and CNS-penetrant treatments.
Speakers : Dr. Davinder Paul - Panelist ,Dr. Tarachand Gupta - Panelist ,Dr. Randeep Singh - Panelist ,Dr. Sushant Mittal - Moderator
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
In this webinar, a detailed discussion is done on Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
Speakers : Dr. Davinder Paul - Panelist ,Dr. Tarachand Gupta - Panelist ,Dr. Randeep Singh - Panelist ,Dr. Sushant Mittal - Moderator
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
Explore Lorlatinib’s role in first-line ALK+ mNSCLC treatment, highlighting key findings from the CROWN trial.`
Speakers : Dr. Davinder Paul - Panelist ,Dr. Tarachand Gupta - Panelist ,Dr. Randeep Singh - Panelist ,Dr. Sushant Mittal - Moderator
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
Explore key findings from the CROWN trial for ALK+ NSCLC patients with CNS metastases and treatment advances.
Speakers : Dr. Sushant Mittal - Moderator ,Dr. Randeep Singh - Panelist ,Dr. Tarachand Gupta - Panelist ,Dr. Davinder Paul - Panelist
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
Cancer during young adulthood carries long-term mental toll, study finds
2.
In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.
3.
Surgery after EGFR TKI shows promise in prolonging progression-free survival in metastatic NSCLC
4.
Every cancer is different because of how evolution causes drug resistance and why various cancers require various treatments.
5.
Report: High risk of lung cancer from respirable crystalline silica even below the current occupational exposure limit
1.
Exploring New Treatment Strategies for Mantle Cell Lymphoma
2.
Essential Techniques in Oncology and Quality Improvement
3.
Molecular Matching for Complex Blood Disorders
4.
Risk Assessment of Reduced Hematopoietic Reserve During Chronic Systemic Stress
5.
Oncology Team Communication Training for Clinical Learners
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
2.
Breast Cancer Awareness and Early Detection
3.
How Advances in Cancer Research Are Improving Treatment Options
4.
Hands-on Workshop: Hematology
5.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge